In the rapidly advancing world of aesthetic treatments, few topics are generating more buzz than exosomes. Marketed as the next big leap in regenerative skincare, exosomes are being hailed for their ability to enhance microneedling results, accelerate healing, and deliver a post-procedure ‘glow’ that patients love.
But amid the excitement, UK practitioners must stay grounded in the legal and insurance realities of using exosomes in clinic. Are they truly worth the investment – or could they leave you exposed?
What are exosomes?
Exosomes are microscopic extracellular vesicles naturally released by cells. They contain growth factors, proteins, lipids, and genetic material, acting like messengers that tell your body’s cells how to repair, regenerate, and respond. In aesthetics, exosomes are most commonly used to:
- Accelerate skin healing after laser or microneedling
- Stimulate collagen production
- Reduce inflammation and redness
- Promote hair follicle activity
Exosomes can be derived from human, animal or plant sources. It’s important to note that human-derived exosomes are not legal in the UK.
Further legalities of exosomes
Injecting exosomes – whether intradermally, subcutaneously, or intravenously – is strictly prohibited under UK law. They may only be applied topically, typically as part of a microneedling treatment.
The Medicines and Healthcare products Regulatory Agency (MHRA) considers exosomes, when injected, a medicinal product, and no exosome-based injectable currently has a UK marketing authorisation.
Practitioners offering exosome injections are therefore:
- Operating outside legal parameters
- Likely voiding their insurance cover
- Potentially facing regulatory sanctions or legal action
It is also worth noting that you must ensure the exosome product you are using is CE marked. With increasing demand, non-CE marked products may become readily accessible, but their use is not legally or ethically acceptable, as they lack the necessary safety and regulatory validation required for patients in the UK.
Any provider offering non-CE marked, injectable or human-based exosomes is not only acting outside regulatory boundaries but also voiding most insurance protections.
Why invest in exosomes?
Many clinics are considering exosomes as they move into expanding their regenerative treatment options or simply as a value-added skin treatment. The reasons are clear:
- Non-invasive (topical)
- Faster recovery post-microneedling or laser
- Reported improvements in tone, texture, and elasticity
- Effective solution for hair regeneration
- Increased revenue potential
However, these benefits come with caveats – especially when it comes to compliance and cover.
Insurance implications you can’t ignore
Before you introduce exosome therapy into your practice, speak to your aesthetic insurance provider. Many practitioners don’t realise that their standard liability cover may not include exosome use, particularly if:
- The product is unregulated or not CE-marked for topical cosmetic use
- The supplier doesn’t meet MHRA (Medicines and Healthcare products Regulatory Agency) standards
- Proper consent and aftercare protocols aren’t in place
Using exosomes outside their legal application (e.g., injection or unlicensed claims) could lead to policy invalidation and regulatory investigation.
Ensure you check:
- Where the product is sourced from (animal or plant acceptable)
- Whether the product is registered and approved for topical cosmetic use
- That you are not crossing into medicinal claims, which could reclassify the product under MHRA regulation
Avoid language that implies curative, antiageing, or medical benefits. Exaggerated or unverified claims could be flagged by the ASA (Advertising Standards Authority) or invite legal challenge if patient results fall short.
Best practices for using exosomes safely
- Keep it topical – Only use exosomes as surface treatments after microneedling or similar procedures.
- Use regulated products – Choose suppliers with documented safety data and CE marking where applicable.
- Update your consent forms – Clearly state that the treatment is non-injectable, cosmetic, and that outcomes may vary.
- Check your policy – Confirm with your insurance provider whether exosomes are covered and under what conditions.
- Document thoroughly – From patient consultations to product batch numbers, good recordkeeping protects you.
Proceed with care
Exosomes can be a powerful tool in your aesthetic toolkit – when used correctly. For UK practitioners, that means topical application only, strict regulatory awareness, and clear communication with patients and insurers. When those boxes are ticked, exosomes can offer real benefits to patients – and real value to your practice.
Want to know if your current insurance policy covers exosome-based treatments? Contact your provider for a policy review, or reach out to our Enhance Insurance team for guidance tailored to UK aesthetic practices.
